vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Industrial Logistics Properties Trust (ILPT). Click either name above to swap in a different company.
Industrial Logistics Properties Trust is the larger business by last-quarter revenue ($113.9M vs $62.1M, roughly 1.8× Cytek Biosciences, Inc.). Industrial Logistics Properties Trust runs the higher net margin — -1.6% vs -70.9%, a 69.4% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 3.1%). Industrial Logistics Properties Trust produced more free cash flow last quarter ($42.0M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 0.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Industrial Logistics Properties Trust is a real estate investment trust that owns and operates a portfolio of industrial and logistics real estate assets primarily across the United States. Its holdings include distribution centers, warehouses, and last-mile delivery properties, serving e-commerce, retail, manufacturing and supply chain operators to meet their storage and logistics operation needs.
CTKB vs ILPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $113.9M |
| Net Profit | $-44.1M | $-1.8M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | -22.1% |
| Net Margin | -70.9% | -1.6% |
| Revenue YoY | 8.1% | 3.1% |
| Net Profit YoY | -557.1% | 92.6% |
| EPS (diluted) | — | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $113.9M | ||
| Q3 25 | $52.3M | $110.9M | ||
| Q2 25 | $45.6M | $112.1M | ||
| Q1 25 | $41.5M | $111.9M | ||
| Q4 24 | $57.5M | $110.5M | ||
| Q3 24 | $51.5M | $108.9M | ||
| Q2 24 | $46.6M | $110.6M | ||
| Q1 24 | $44.9M | $112.2M |
| Q4 25 | $-44.1M | $-1.8M | ||
| Q3 25 | $-5.5M | $-21.6M | ||
| Q2 25 | $-5.6M | $-21.3M | ||
| Q1 25 | $-11.4M | $-21.5M | ||
| Q4 24 | $9.6M | $-24.1M | ||
| Q3 24 | $941.0K | $-25.0M | ||
| Q2 24 | $-10.4M | $-23.2M | ||
| Q1 24 | $-6.2M | $-23.4M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | -22.1% | ||
| Q3 25 | -17.6% | -29.4% | ||
| Q2 25 | -23.3% | -30.8% | ||
| Q1 25 | -36.1% | -26.9% | ||
| Q4 24 | 5.2% | -31.1% | ||
| Q3 24 | -8.2% | -33.5% | ||
| Q2 24 | -18.3% | -32.4% | ||
| Q1 24 | -23.9% | -31.7% |
| Q4 25 | -70.9% | -1.6% | ||
| Q3 25 | -10.5% | -19.4% | ||
| Q2 25 | -12.2% | -19.0% | ||
| Q1 25 | -27.5% | -19.2% | ||
| Q4 24 | 16.8% | -21.8% | ||
| Q3 24 | 1.8% | -22.9% | ||
| Q2 24 | -22.4% | -20.9% | ||
| Q1 24 | -13.8% | -20.9% |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.33 | ||
| Q2 25 | — | $-0.32 | ||
| Q1 25 | — | $-0.33 | ||
| Q4 24 | — | $-0.37 | ||
| Q3 24 | — | $-0.38 | ||
| Q2 24 | — | $-0.35 | ||
| Q1 24 | — | $-0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $94.8M |
| Total DebtLower is stronger | — | $4.2B |
| Stockholders' EquityBook value | $341.7M | $489.7M |
| Total Assets | $461.5M | $5.2B |
| Debt / EquityLower = less leverage | — | 8.56× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $94.8M | ||
| Q3 25 | $93.3M | $83.2M | ||
| Q2 25 | $75.5M | $58.6M | ||
| Q1 25 | $95.3M | $108.0M | ||
| Q4 24 | $98.7M | $131.7M | ||
| Q3 24 | $162.3M | $153.9M | ||
| Q2 24 | $177.9M | $146.2M | ||
| Q1 24 | $168.8M | $128.4M |
| Q4 25 | — | $4.2B | ||
| Q3 25 | — | $4.2B | ||
| Q2 25 | — | $4.2B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $4.3B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.3B | ||
| Q1 24 | — | $4.3B |
| Q4 25 | $341.7M | $489.7M | ||
| Q3 25 | $378.6M | $494.1M | ||
| Q2 25 | $377.6M | $519.1M | ||
| Q1 25 | $379.6M | $539.5M | ||
| Q4 24 | $395.7M | $562.0M | ||
| Q3 24 | $385.5M | $585.9M | ||
| Q2 24 | $389.1M | $618.3M | ||
| Q1 24 | $392.6M | $643.2M |
| Q4 25 | $461.5M | $5.2B | ||
| Q3 25 | $494.9M | $5.2B | ||
| Q2 25 | $493.3M | $5.2B | ||
| Q1 25 | $482.6M | $5.4B | ||
| Q4 24 | $499.5M | $5.4B | ||
| Q3 24 | $491.2M | $5.5B | ||
| Q2 24 | $483.7M | $5.5B | ||
| Q1 24 | $492.1M | $5.5B |
| Q4 25 | — | 8.56× | ||
| Q3 25 | — | 8.49× | ||
| Q2 25 | — | 8.09× | ||
| Q1 25 | — | 7.96× | ||
| Q4 24 | — | 7.65× | ||
| Q3 24 | — | 7.35× | ||
| Q2 24 | — | 6.96× | ||
| Q1 24 | — | 6.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $60.7M |
| Free Cash FlowOCF − Capex | $-1.8M | $42.0M |
| FCF MarginFCF / Revenue | -2.9% | 36.9% |
| Capex IntensityCapex / Revenue | 1.6% | 16.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $79.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $60.7M | ||
| Q3 25 | $-3.9M | $22.7M | ||
| Q2 25 | $108.0K | $18.4M | ||
| Q1 25 | $-125.0K | $11.4M | ||
| Q4 24 | $2.0M | $2.0M | ||
| Q3 24 | $13.2M | $-3.4M | ||
| Q2 24 | $6.2M | $10.8M | ||
| Q1 24 | $4.0M | $8.0M |
| Q4 25 | $-1.8M | $42.0M | ||
| Q3 25 | $-4.6M | $17.6M | ||
| Q2 25 | $-1.5M | $15.2M | ||
| Q1 25 | $-974.0K | $5.0M | ||
| Q4 24 | $1.1M | $-3.7M | ||
| Q3 24 | $12.2M | $-5.9M | ||
| Q2 24 | $5.2M | $9.4M | ||
| Q1 24 | $3.4M | $5.9M |
| Q4 25 | -2.9% | 36.9% | ||
| Q3 25 | -8.7% | 15.9% | ||
| Q2 25 | -3.2% | 13.5% | ||
| Q1 25 | -2.3% | 4.5% | ||
| Q4 24 | 1.9% | -3.4% | ||
| Q3 24 | 23.7% | -5.5% | ||
| Q2 24 | 11.0% | 8.5% | ||
| Q1 24 | 7.6% | 5.2% |
| Q4 25 | 1.6% | 16.4% | ||
| Q3 25 | 1.3% | 4.6% | ||
| Q2 25 | 3.5% | 2.9% | ||
| Q1 25 | 2.0% | 5.7% | ||
| Q4 24 | 1.6% | 5.2% | ||
| Q3 24 | 2.0% | 2.3% | ||
| Q2 24 | 2.3% | 1.3% | ||
| Q1 24 | 1.3% | 1.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
ILPT
Segment breakdown not available.
